Table of Contents
Erratum

An erratum for this article has been published. To view the erratum, please click here.

Journal of Amino Acids
Volume 2011 (2011), Article ID 721094, 6 pages
http://dx.doi.org/10.4061/2011/721094
Research Article

Decreased Phosphorylation and Increased Methionine Oxidation of α-Synuclein in the Methionine Sulfoxide Reductase A Knockout Mouse

Department of Pharmacology and Toxicology, School of Pharmacy, The University of Kansas, Lawrence, KS 66045, USA

Received 31 October 2010; Accepted 11 December 2010

Academic Editor: Gal Bitan

Copyright © 2011 Derek B. Oien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. B. Lücking and A. Brice, “Alpha-synuclein and Parkinson's disease,” Cellular and Molecular Life Sciences, vol. 57, no. 13-14, pp. 1894–1908, 2000. View at Google Scholar · View at Scopus
  2. M. Baba, S. Nakajo, P. H. Tu et al., “Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies,” American Journal of Pathology, vol. 152, no. 4, pp. 879–884, 1998. View at Google Scholar · View at Scopus
  3. E. Lindersson, R. Beedholm, P. Højrup et al., “Proteasomal inhibition by α-synuclein filaments and oligomers,” Journal of Biological Chemistry, vol. 279, no. 13, pp. 12924–12934, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Sawada, R. Kohno, T. Kihara et al., “Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes α-synuclein inclusions,” Journal of Biological Chemistry, vol. 279, no. 11, pp. 10710–10719, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Snyder, K. Mensah, C. Hsu et al., “β-synuclein reduces proteasomal inhibition by α-synuclein but not γ-synuclein,” Journal of Biological Chemistry, vol. 280, no. 9, pp. 7562–7569, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Vekrellis, H. J. Rideout, and L. Stefanis, “Neurobiology of α-synuclein,” Molecular Neurobiology, vol. 30, no. 1, pp. 1–21, 2004. View at Google Scholar · View at Scopus
  7. B. I. Giasson, J. E. Duda, I. V. J. Murray et al., “Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions,” Science, vol. 290, no. 5493, pp. 985–989, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. L. J. Hsu, Y. Sagara, A. Arroyo et al., “α-synuclein promotes mitochondrial deficit and oxidative stress,” American Journal of Pathology, vol. 157, no. 2, pp. 401–410, 2000. View at Google Scholar · View at Scopus
  9. J. Moskovitz, “Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases,” Biochimica et Biophysica Acta, vol. 1703, no. 2, pp. 213–219, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. D. B. Oien and J. Moskovitz, “Substrates of the methionine sulfoxide reductase system and their physiological relevance,” Current Topics in Developmental Biology, vol. 80, pp. 93–133, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Moskovitz, “Prolonged selenium deficient diet in MsrA knockout mice causes enhanced oxidative modification to proteins and affects the levels of antioxidant enzymes in a tissue-specific manner,” Free Radical Research, vol. 41, no. 2, pp. 162–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Moskovitz and E. R. Stadtman, “Selenium-deficient diet enhances protein oxidation and affects methionine sulfoxide reductase (MsrB) protein level in certain mouse tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7486–7490, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Moskovitz, M. A. Rahman, J. Strassman et al., “Escherichia coli peptide methionine sulfoxide reductase gene: regulation of expression and role in protecting against oxidative damage,” Journal of Bacteriology, vol. 177, no. 3, pp. 502–507, 1995. View at Google Scholar · View at Scopus
  14. J. Moskovitz, B. S. Berlett, J. M. Poston, and E. R. Stadtman, “The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 18, pp. 9585–9589, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Moskovitz, E. Flescher, B. S. Berlett, J. Azare, J. M. Poston, and E. R. Stadtman, “Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 24, pp. 14071–14075, 1998. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Moskovitz, S. Bar-Noy, W. M. Williams, J. Requena, B. S. Berlett, and E. R. Stadtman, “Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 23, pp. 12920–12925, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Pal, D. B. Oien, F. Y. Ersen, and J. Moskovitz, “Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase a knockout mouse,” Experimental Brain Research, vol. 180, no. 4, pp. 765–774, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Oien and J. Moskovitz, “Protein-carbonyl accumulation in the non-replicative senescence of the methionine sulfoxide reductase A (msrA) knockout yeast strain,” Amino Acids, vol. 32, no. 4, pp. 603–606, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. J. S. Berke and H. L. Paulson, “Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegeneration,” Current Opinion in Genetics and Development, vol. 13, no. 3, pp. 253–261, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. D. B. Oien, T. Canello, R. Gabizon et al., “Detection of oxidized methionine in selected proteins, cellular extracts and blood serums by novel anti-methionine sulfoxide antibodies,” Archives of Biochemistry and Biophysics, vol. 485, no. 1, pp. 35–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ishii, T. Nonaka, S. Taniguchi et al., “Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human α-synuclein: implication for α-synucleinopathies,” FEBS Letters, vol. 581, no. 24, pp. 4711–4717, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. D. B. Oien, H. E. Shinogle, D. S. Moore, and J. Moskovitz, “Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells,” Journal of Molecular Neuroscience, vol. 39, no. 3, pp. 323–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Liu, J. Hindupur, J. L. Nguyen et al., “Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson's disease-related insults,” Free Radical Biology and Medicine, vol. 45, no. 3, pp. 242–255, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. C. Hardin, C. T. Larue, M. H. Oh, V. Jain, and S. C. Huber, “Coupling oxidative signals to protein phosphorylation via methionine oxidation in Arabidopsis,” Biochemical Journal, vol. 422, no. 2, pp. 305–312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. D. B. Oien, G. L. Osterhaus, B. L. Lundquist, S. C. Fowler, and J. Moskovitz, “Caloric restriction alleviates abnormal locomotor activity and dopamine levels in the brain of the methionine sulfoxide reductase A knockout mouse,” Neuroscience Letters, vol. 468, no. 1, pp. 38–41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Fujiwara, M. Hasegawa, N. Dohmae et al., “α-synuclein is phosphorylated in synucleinopathy lesions,” Nature Cell Biology, vol. 4, no. 2, pp. 160–164, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Chen and M. B. Feany, “α-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease,” Nature Neuroscience, vol. 8, no. 5, pp. 657–663, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. K. E. Paleologou, A. W. Schmid, C. C. Rospigliosi et al., “Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein,” Journal of Biological Chemistry, vol. 283, no. 24, pp. 16895–16905, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. C. C. Chao, Y. S. Ma, and E. R. Stadtman, “Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 2969–2974, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Zhou, C. Long, S. H. Reaney, D. A. Di Monte, A. L. Fink, and V. N. Uversky, “Methionine oxidation stabilizes non-toxic oligomers of α-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions,” Biochimica et Biophysica Acta, vol. 1802, no. 3, pp. 322–330, 2010. View at Publisher · View at Google Scholar
  31. W. Zhou, A. Gallagher, D. P. Hong, C. Long, A. L. Fink, and V. N. Uversky, “At low concentrations, 3,4-dihydroxyphenylacetic acid (DOPAC) binds non-covalently to α-synuclein and prevents its fibrillation,” Journal of Molecular Biology, vol. 388, no. 3, pp. 597–610, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. C. B. Glaser, G. Yamin, V. N. Uversky, and A. L. Fink, “Methionine oxidation, α-synuclein and Parkinson's disease,” Biochimica et Biophysica Acta, vol. 1703, no. 2, pp. 157–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. J. Hokenson, V. N. Uversky, J. Goers, G. Yamin, L. A. Munishkina, and A. L. Fink, “Role of individual methionines in the fibrillation of methionine-oxidized α-synuclein,” Biochemistry, vol. 43, no. 15, pp. 4621–4633, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Yamin, C. B. Glaser, V. N. Uversky, and A. L. Fink, “Certain metals trigger fibrillation of methionine-oxidized α-synuclein,” Journal of Biological Chemistry, vol. 278, no. 30, pp. 27630–27635, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. V. N. Uversky, G. Yamin, P. O. Souillac, J. Goers, C. B. Glaser, and A. L. Fink, “Methionine oxidation inhibits fibrillation of human α-synuclein in vitro,” FEBS Letters, vol. 517, no. 1–3, pp. 239–244, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Rekas, R. B. Knott, A. Sokolova et al., “The structure of dopamine induced α-synuclein oligomers,” European Biophysics Journal, vol. 39, pp. 1407–1419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. SU. L. Leong, C. L. L. Pham, D. Galatis et al., “Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation,” Free Radical Biology and Medicine, vol. 46, no. 10, pp. 1328–1337, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Zhu, Z. J. Qin, D. Hu, L. A. Munishkina, and A. L. Fink, “α-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles,” Biochemistry, vol. 45, no. 26, pp. 8135–8142, 2006. View at Publisher · View at Google Scholar · View at Scopus